Literature DB >> 4027184

The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population.

R M MacKie, J English, T C Aitchison, C P Fitzsimons, P Wilson.   

Abstract

Total body mole counts have been performed on 432 normal healthy Caucasian subjects aged 4 days to 96 years (204 males and 228 females). The mean total body mole count in the first decade of life is three for females and two for males, rising rapidly in the second decade to a mean of 23 for females and 18 for males. In the third decade numbers are highest, with a mean of 33 for females and 22 for males. Thereafter, numbers of moles slowly drop until in the eighth decade they have fallen to levels similar to those seen in pre-pubertal children. There is a significant association between the presence of naevi in early childhood (prior to 5 years of age) and the development in later life of large numbers of moles. In women there is no significant association between total mole counts and either parity or use of the oral contraceptive.

Entities:  

Keywords:  Age Distribution; Age Factors; Biology; Contraception; Contraceptive Agents, Female; Dermatitis; Dermatological Effects; Developed Countries; Diseases; England; Europe; Evaluation; Evaluation Methodology; Fertility Measurements; Incidence; Measurement; Melanosis; Northern Europe; Oral Contraceptives; Parity; Physiology; Population Characteristics; Research Methodology; United Kingdom

Mesh:

Substances:

Year:  1985        PMID: 4027184     DOI: 10.1111/j.1365-2133.1985.tb02060.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  42 in total

1.  Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy.

Authors:  E Ballone; M Passamonti; G Lappa; G Di Blasio; P Fazii
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

Review 2.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

3.  Relation between phenotype and banal melanocytic naevi.

Authors:  J S English; A J Swerdlow; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

4.  Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.

Authors:  M Fonseca; M A Marchetti; E Chung; S W Dusza; M E Burnett; A A Marghoob; A C Geller; M Bishop; A Scope; A C Halpern
Journal:  Br J Dermatol       Date:  2015-10-27       Impact factor: 9.302

5.  Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations.

Authors:  Toni E Burbidge; Boris C Bastian; Danny Guo; Haocheng Li; Don G Morris; Jose G Monzon; Gabriella Leung; Huiming Yang; Tina Cheng
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

6.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

7.  Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults.

Authors:  Anne E Cust; Kristen M Pickles; Chris Goumas; Thao Vu; Helen Schmid; Eduardo Nagore; John Kelly; Joanne F Aitken; Graham G Giles; John L Hopper; Mark A Jenkins; Graham J Mann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-27       Impact factor: 4.254

8.  Benign melanocytic naevi as a risk factor for malignant melanoma.

Authors:  A J Swerdlow; J English; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-14

9.  Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib.

Authors:  Philip R Cohen; Agop Y Bedikian; Kevin B Kim
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

10.  Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration.

Authors:  T M Mack; B Floderus
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.